Emvision Medical Devices Ltd (EMV) - Total Liabilities
Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has total liabilities worth AU$5.20 Million AUD (≈ $3.68 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Emvision Medical Devices Ltd - Total Liabilities Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Emvision Medical Devices Ltd to evaluate short-term liquidity relative to the company's equity base.
Emvision Medical Devices Ltd Competitors by Total Liabilities
The table below lists competitors of Emvision Medical Devices Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SA Catana Group
PA:CATG
|
France | €126.23 Million |
|
Creades AB Series A
LSE:0QI9
|
UK | Skr39.00 Million |
|
Pacific Construction Co Ltd
TW:2506
|
Taiwan | NT$4.97 Billion |
|
Nordhealth AS
OL:NORDH
|
Norway | Nkr9.97 Million |
|
PS International Group Ltd. Ordinary Shares
NASDAQ:PSIG
|
USA | $38.17 Million |
|
Kalaris Therapeutics, Inc.
NASDAQ:KLRS
|
USA | $41.25 Million |
|
OMER S.P.A. O.N.
F:9WR
|
Germany | €32.09 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Emvision Medical Devices Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EMV market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Emvision Medical Devices Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual total liabilities of Emvision Medical Devices Ltd from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$6.29 Million ≈ $4.45 Million |
+15.33% |
| 2024-06-30 | AU$5.46 Million ≈ $3.86 Million |
-14.79% |
| 2023-06-30 | AU$6.40 Million ≈ $4.53 Million |
+349.10% |
| 2022-06-30 | AU$1.43 Million ≈ $1.01 Million |
+98.00% |
| 2021-06-30 | AU$720.01K ≈ $509.45K |
+47.02% |
| 2020-06-30 | AU$489.73K ≈ $346.51K |
+6.45% |
| 2019-06-30 | AU$460.06K ≈ $325.52K |
+37.08% |
| 2018-06-30 | AU$335.61K ≈ $237.46K |
-- |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more